Learn more

KIM HYUN KEE

Overview
  • Total Patents
    81
  • GoodIP Patent Rank
    213,759
About

KIM HYUN KEE has a total of 81 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Republic of Korea, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are PROGENITOR INC, BAKER KEVIN P and GODDARD AUDREY.

Patent filings per year

Chart showing KIM HYUN KEEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Hyun Kee 65
#2 Kim Jin Woo 47
#3 Kim Jin-Woo 8
#4 Kim Hyun-Kee 5
#5 Yoon Soo Min 1
#6 Shin Gi Won 1
#7 Hwang Hee Sung 1
#8 Kim Min Soo 1
#9 Chung Junho 1
#10 Jung Gyoo Yeol 1

Latest patents

Publication Filing date Title
KR20140146028A Composition for Detection of Small Hepatocellular Carcinoma and Hepatocellular Carcinoma Latent in a Cirrhotic Liver
KR20150118870A Spectacles having single body type nose pad
KR20140029510A Composition for improving recognition and treating or preventing alzheimer's disease comprising galla rhois extract
CN105452865A Composition for diagnosing small hepatocellular carcinoma and hepatocellular carcinoma latent in cirrhotic liver
WO2015020241A1 Composition containing galla rhois extract as active ingredient for improving cognition and preventing or treating alzheimer's disease
KR20130045888A Composition for diagnosing and /or treating cancer and the kit
KR20140111726A Glasses hinge assembling structure
KR20140039904A Method of molding front of spectacles having single body type nose pad
KR20130112508A Composition for detection of small hepatocellular carcinoma and hepatocellular carcinoma latent in a cirrhotic liver
KR20130108821A Composition for improving recognition and treating or preventing alzheimer's disease comprising galla rhois extract
KR20120140097A Composition and method for diagnosis and treatment of human cancer
KR20120095722A Gene signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib
KR20120021518A Composition and method for diagnosing hepatocellular carcinoma
KR20110110638A Composition for improving recognition comprising galla rhois extract
KR20090120771A Composition for inducing tumorigenesis, transdifferentiation, and kidney development comprising hccr-1 or hccrbp-1 protein
KR20090116336A Method and composition for detecting hccr-1 expression level to prognose estrogen receptor positive, progesterone receptor positive, p53 tumor suppressor gene mutation and her2-positive breast cancer
KR20090042036A Human cancer suppressor gene, protein encoded therein, expression vector containing same, and cell transformed by said vector
KR20090042030A Human protooncogene and protein encoded therein
KR20080066252A Novel proliferation marker in papillary thyroid carcinoma and novel method of diagnosis detecting the marker
KR20080058105A Human protooncogene, protein encoded by same, expression vector containing same, and cell transformed by said vector